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ABSTRACT Improved care in pulmonary arterial hypertension has led to increased longevity for
patients, with a paralleled evolution in the nature of their needs. There is more focus on the impact of the
disease on their day-to-day activities and quality of life, and a holistic approach is coming to the front of
pulmonary arterial hypertension management, which places the patient at the centre of their own
healthcare. Patients are thus becoming more proactive, involved and engaged in their self-care, and this
engagement is an important factor if patient outcomes are to improve. In addition, involvement of the
patient may improve their ability to cope with pulmonary arterial hypertension, as well as help them to
become effective in the self-management of their disease. Successful patient engagement can be achieved
through effective education and the delivery and communication of timely, high-quality information. A
multidisciplinary approach involving healthcare professionals, carers, patient associations and expert
patient programmes can also encourage patients to engage. Strategies that promote patient engagement can
help to achieve the best possible care and support for the patient and also benefit healthcare providers.
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The evolving needs of PAH requires patients to participate in self-management of their disease
http://ow.ly/uT79305pyyj
Introduction
Pulmonary arterial hypertension (PAH) has evolved from a disease with a poor prognosis to a disease that
patients can live with over the long term [1, 2]. A range of treatment options, together with specialist
healthcare, have led to improved outcomes for PAH patients in terms of symptom management and
disease progression [3, 4]. As PAH patients live longer [2], challenges arise that go beyond the treatment
of symptoms. The majority of patients report that PAH has a “very significant impact” on daily life,
affecting physical ability, working life, income, household chores, intimacy and emotional well-being [5, 6].
An increased focus on the quality of life (QoL) [2, 7] and evolving needs of PAH patients necessitates an
approach that encourages them to participate in the self-management of their disease. As many patients
organise their day-to-day activities and disease management alone, there is a need for them to receive
support towards furthering their own self-care.
Traditionally, the role of the patient has generally been passive when receiving medical advice and
treatment [8]. Today, there is a growing need for patients to become active participants in their own care
[9]. Such “activated” patients are engaged, seek out information [10] and participate in the management of
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their disease by being involved in decision making and taking action with regards to their care [10]. As a
result, activated patients experience better health outcomes at a lower healthcare cost [9, 11, 12].
An active partnership between patients and healthcare professionals (HCPs), incorporating education and
support for self-management, is essential for the optimal management of chronic illness [8] and should be
integrated from the time of diagnosis [10]. This review describes the roles and challenges faced by HCPs,
patient associations and expert patients in encouraging patient engagement in PAH. It draws upon the
authors’ own experience as well as feedback from other representatives of patients and HCPs shared at
workshops focused on patient engagement.
The importance of patient engagement and current challenges in PAH
To better understand patient engagement, it is useful to differentiate the concept of patient engagement
from other terms that are often used in the literature, such as patient empowerment and patient activation.
Patient empowerment is a concept that is psychological in nature and describes the patients’ subjective
sense of control over their own disease and treatment management and the feeling of being directly
responsible for their own health outcomes [13, 14]. Patient activation refers to an “individual’s knowledge,
skill and confidence in managing his/her own health and healthcare” [15]. Patient activation can be
thought of as having four stages (figure 1) [9, 16]. In stage one the patient must believe that their role is
important in managing their own health. Having the confidence and knowledge necessary to take action is
defined as stage two. Stage three is reached when the patient takes action to maintain and improve their
health and stage four is achieved when the patient continues with self-management, even under stress. In
practice, the process is not linear for all patients and an individual may go back a stage or be in different
stages for different aspects of their disease. Patients often have different attitudes when dealing with their
health [17] and this can have an impact on the activation process. Patient activation, although often used
synonymously with patient engagement, is just one aspect of an individual’s ability to engage in their own
care [12]. Patient engagement extends further and is often used as an umbrella term that covers different
aspects of patient interaction with their healthcare system [18] at various stages of their disease [12].
A substantial evidence base suggests that patient engagement in general improves patient outcomes [8, 12, 19].
PAH patients who feel well-informed find it easier to cope with their disease [20] and informed patients who
receive comprehensive guidance have better outcomes [2]. Patients who are involved in the decision making
regarding their disease are more engaged and motivated. Patients with chronic conditions who attended a
self-management programme reported significant improvements in patient activation [21]. Further
improvements were reported across a range of measures, including health-related QoL, health status, anxiety,
depression and self-management skills [21]. The importance of shared decision making, where PAH patients
express their preferences with regards to their care, has been documented [7, 10]. Patients who understand the
benefits of being actively involved in decisions about their treatment and care are able to make informed
decisions and to take ownership of their disease, which leads to improved outcomes [8].
A number of challenges exist in the engagement of PAH patients. There is a need for more education, with
both PAH patients and their carers stating that they would like more information about the disease [5, 6, 20].
Know your own health
Stage 1
All faith in doctors
Passive behaviours
Helplessness
Isolation
Information about 
personal health situation
Communication skills
Health literacy
Self-care support
Decision-making
Being connected
Take action
Find information
Organise questions
Map options and choices
Stage 2
ActivatedPassive
Stage 3 Stage 4
FIGURE 1 Four potential stages of patient activation. Reproduced from [10].
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This includes the emotional impact of PAH, treatment options and the implications of different modes of drug
administration [5]. Patients have highlighted a lack of sufficient information exchange between expert PAH
teams and local HCPs [6, 7] and, therefore, communication between HCPs should be improved [10]. A wealth
of information on PAH is already available to patients; nevertheless, there is a need to optimise its delivery and
communication. Patients increasingly seek information about PAH on the internet [6] and it is vital that this
information is correct and that HCPs are aware of sources of high-quality information. The optimal timing and
method of delivery of information to patients should reflect their changing needs over time [10]. Cognitive
function can be impaired in PAH, affecting verbal learning, memory, decision making and motor function
[22]. This may limit the patient’s ability to engage and self-manage their disease. A further challenge is that
some patients may not wish to be engaged in the management of their disease. Being engaged and active
means confronting and learning to deal with the facts about their disease. For some individuals, choosing not
to engage may be a coping mechanism in a disease with a harsh reality. The benefits of being an engaged
patient should be communicated to these patients.
How can we engage patients and better meet their information needs?
A multidimensional framework has been devised for the development of interventions and policies that
support patient and family engagement [12]. The framework highlights different ways in which patients
can engage across the healthcare system and the levels at which this can occur throughout the course of
the disease. It examines the factors that can influence patients’ willingness and ability to be engaged in
their disease and the impact that can be achieved by implementing policies that increase engagement
across multiple levels (figure 2) [12].
Patient engagement is best initiated in a multidisciplinary environment [2] by an expert team of HCPs with a
diverse set of skills and experience who are best able to support the PAH patient [20, 23]. The European
Society of Cardiology/European Respiratory Society guidelines recommend that the PAH team collaborates
with other professionals, including psychologists, psychiatrists, social workers and patient associations [3, 4].
Such a multidisciplinary environment can only realistically be provided in large-volume expert centres and
many patients will live far from such centres. These patients will require additional support and management
from their local family doctors and possibly HCPs in shared care centres, necessitating good communication
and patient-held records for optimal patient management. A collaborative approach between HCPs, patients
associations, carers and expert patient programmes can optimise patient engagement.
Levels of engagement
Continuum of engagement
Consultation Involvement Partnership and shared leadership
Direct care
Patients receive 
information about a diagnosis
Patients are asked about 
their preferences in 
treatment plan
Treatment decisions are made 
based on patients’ preferences, 
medical evidence and clinical 
judgement
Organisational design 
and governance
Organisation surveys patients 
about their care experiences
Hospital involves patients
as advisers or advisory 
council members
Patients co-lead hospital safety 
and quality improvement 
committees
Policy making
Public agency conducts focus 
groups with patients to ask 
opinions about a healthcare issue
Factors influencing engagement:
Patient (beliefs about patient role, health literacy, education)
Organisation (policies and practices, culture)
Society (social norms, regulations, policy)
Patients’ recommendations 
about research priorities are 
used by public agency to make 
funding decisions
Patients have equal 
representation on agency
committee that makes decisions 
about how to allocate resources 
to health programmes
FIGURE 2 Multidimensional framework for patient and family engagement. A number of factors influence whether and to what extent patients
engage at different points along the continuum of engagement. These factors can be grouped into three levels of engagement related to patients,
organisations and society. Increased patient participation and collaboration is observed with increased shift to the right on the continuum of
engagement. Reproduced from Project HOPE/Health Affairs [12] with permission from the publisher.
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Providing timely, individualised information to PAH patients
PAH patients require a range of information encompassing treatment options, the physical and personal
impact of PAH and/or treatment, emotional well-being and socioeconomic factors. Patients need an
understanding of what their treatment involves, including the practical aspects of how to manage titration
procedures and complicated drug delivery systems (such as intravenous and subcutaneous pumps). PAH
patients often have a restricted ability to carry out their daily activities, which may leave them feeling frustrated
and angry [5]. Therefore, advice on the impact of the physical restrictions that PAH can impose on patients is
crucial. Practical support for PAH patients is discussed in more detail in the article by FARBER and GIN-SING
[24] in this issue of the European Respiratory Review. PAH patients often have financial burdens resulting from
their reduced ability to work, which may lead to frustration, anger and low self-esteem [5]. Indeed, a
significant proportion of PAH patients suffer from depression [25]. Informing women that pregnancy is high
risk in PAH is essential [2], as is providing personalised advice on suitable methods of family planning. This is
discussed further in the article by OLSSON and CHANNICK [26] in this issue of the European Respiratory Review.
Carers and families of patients, including children, also benefit from receiving appropriate information on
PAH, as they need to understand the challenges of the disease, how it will impact their daily life and how
they may be able to help the patients [27]. By attending clinic appointments with the patient, family
members can learn about PAH and contribute to the patient’s individualised treatment plan [27]. Tailored
resources to support parents in explaining their disease to children have been developed, including the
Medikidz comic book range that helps children understand complex diseases [10].
Patients require high-quality information [28], tailored to the individual [10] and disseminated at the
appropriate time. Patients have reported a desire to receive information that is staggered throughout the
course of their disease [5]. At diagnosis, patients wish to receive information on the disease and its treatment
[5]. At later stages, patients request patient stories, testimonials and information on the effect of PAH on
travel and sexual relationships [5]. Patient stories and shared experiences can help patients to manage their
own disease, offering support as patients strive to find solutions to their own individual challenges.
Incorrect or inappropriate information may lead to misconceptions and the patient becoming passive in
their self-care. Online material on PAH may carry with it a particularly high risk of misinformation.
Case 1 in figure 3 is a real-life example where initial information obtained from the internet led a woman
with PAH to refuse treatment. Following the provision of correct information and relevant education, the
patient embraced sequential therapy. Many years later she remains engaged, involved in her own care and
helps others in the management of their disease.
Case 1:
50-year-old female diagnosed with FC III 
  IPAH was recommended PAH-specific   
  treatment
Patient refused treatment since she had 
  read about the poor prognosis of PAH on 
  the internet and consequently wanted to be 
  left alone to die
Following face-to-face discussion, education 
  from clinical nurse specialists and 
  provision of a bespoke patient handbook, 
  the patient embraced sequential PAH 
  therapy
8 years later, the patient is now in FC II, 
  working as an expert patient and 
  participating in clinical trials
Case 2:
Four patients (32–51 years old) met with a 
  multidisciplinary HCP team
The joint meeting was planned for the 
  patients to share information and learn 
  from each other
The patients were engaged and asked a lot 
  of questions
The patients have been willing to inform 
  and guide new patients with PAH
Today three of these patients are active in 
  patient associations
Multidisciplinary HCP expertise
Patient expertise
Expert patient programme
Patient associations
FIGURE 3 Real-life pulmonary arterial hypertension (PAH) patient cases to reflect the importance of a
collaborative approach to patient engagement. Case 1 reflects the importance of accurate information being
given to the patient at the time of PAH diagnosis. Case 2 reflects the value of shared patient appointments,
indicating how different approaches can benefit different patients. The coloured circles represent the
elements of the collaborative approach to patient engagement used in each of the cases. FC: functional class;
HCP: healthcare professional; IPAH: idiopathic PAH.
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Patients differ in their preferred way of learning and, therefore, the dissemination of information needs to
match the individual [27]. Some patients prefer reading at home rather than being overwhelmed during
visits with HCPs. Some may need time to process information before asking questions at a later stage
while others may require immediate answers at appointments. Patients may prefer the approach of shared
medical appointments, where several patients are invited to meet with the multidisciplinary team in a
group setting. This can allow PAH patients to increase their understanding of the disease, while
integrating peer support, promoting social interaction and addressing patients’ emotional needs [29].
Case 2 in figure 3 is an example of how shared appointments contributed to patient engagement with
their disease. This led to participation in patient associations by some of those in the group.
Awareness of a patient’s health literacy is integral to patient care, safety, education and counselling [30].
Health literacy is the degree to which individuals have the capacity to obtain, process and understand basic
health information and services needed to make informed health decisions [31]. Patient health literacy
can easily be overestimated [30] and care must be taken to ensure patients understand the information
they are given.
Role of HCPs
The first contact with a HCP provides an opportunity for the PAH patient to talk and ask questions,
whilst allowing the HCP to gain an understanding of the patient’s needs in terms of education and
information. Too much information can often be overwhelming [5] and patients may vary in the degree to
which they benefit from participation in patient education due to disease burden, literacy levels and
socioeconomic factors [32]. HCPs must gauge what level of information is appropriate and how much
information the patient is able to process and retain at different stages of their disease. Notably, there are
often differences between the expectations of the patient and those of the HCP in terms of PAH
management. While expectations of HCPs tend to focus on functional aspects of PAH, patients’
expectations tend to focus on the effect on overall QoL, treatment convenience and the physiological and
physical impact on their lives [7, 33]. There is increasing use of health-related QoL assessments and
questionnaires in clinical practice, designed to assess patients’ symptoms and function, as well as other
patient-related measures [2, 34]. These tools can be used to help HCPs better understand the needs of
individual patients [34] and stimulate discussion about aspects of patients’ lives other than those which are
purely physiological [7, 33], such as exercise capacity and optimising right ventricular function.
Management of PAH patients in expert referral centres with a specialist team is beneficial as it ensures that
regular contact with HCPs, including clinical pulmonary hypertension nurse specialists, is maintained [2–4].
Even with the availability of regional satellite clinics, it is preferable for patients to maintain regular contact
with PAH expert referral centres and not to be seen exclusively in a satellite clinic. Patients would like more
opportunities to discuss their disease and its impact on everyday life with HCPs [5, 6] and to be continuously
updated by them [6]. In a multidisciplinary team, different HCPs have complementary roles and follow-up
and long-term support of patients is shared with local HCPs [2], who in turn should be well-informed about
PAH and maintain a constant dialogue with specialist pulmonary hypertension centres [2].
It is the responsibility of all HCPs to make sure the patient understands the information that is being
delivered. Healthcare team members should receive training on how to better engage patients to participate
in their own care, including communication skills, making shared decisions and understanding patient
information needs [10]. It is also important to ensure that some members of a team delivering pulmonary
hypertension care are trained in health coaching, since this can help patients gain a better understanding
of their goals, how to achieve them and how to engage in the management of their chronic condition [35].
Incorporation of an awareness of oral and aural literacy into community programmes and healthcare
provider education and training is also recommended [36]. For patients to adhere to a treatment plan, they
must understand basic information about the tasks for which they are responsible. If this information is
not presented clearly using language the patient can easily understand, it can compromise patients’
agreement, motivation and commitment [37]. In this respect, patients may also benefit from receiving
information from a variety of HCPs because each individual may convey information differently. The
“teach back” tool is often used in specialised centres to evaluate HCPs on their delivery of information to
the patient [38]. With this tool, patients have to re-transcribe the information delivered, such as
instructions for medication use or a description of a proposed procedure, to ascertain whether they have
understood correctly [39]. Another method of delivering information is via web-based forums that are
designed for PAH patients, where specialists answer patient questions [6]. HCPs can also learn about the
patient experience, in order to better tailor how they deliver information and care to patients, through
observing patients in group discussion (e.g., the “Goldfish Bowl” model) [40].
A number of practical solutions have been developed to promote patient engagement and empower them to
take ownership of their disease. These include tools such as “information prescriptions”, written care plans,
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patient “passports”, self-management courses, patient-to-patient mentoring and the promotion of patient
associations [10] (table 1). These tools allow the delivery of high-quality information in a way that is tailored
to the needs of the individual, providing education and support to the PAH patient. A holistic approach,
incorporating training for HCPs, can further enhance patient engagement [10].
TABLE 1 Practical solutions for a holistic approach to the engagement of pulmonary arterial hypertension (PAH) patients
Practical solution Considerations for implementing practical solutions
Training for HCPs and other multidisciplinary team members The benefits of patient engagement and self-management
How to work collaboratively with patients to motivate them to participate in
their own care
Communicating with patients using language that is easy for them to
understand
Helping patients to understand and communicate their fears and establish
their own goals
Managing the broader aspects of PAH beyond the physical symptoms
Understanding the support and services available from patient associations
Specific training for HCPs in shared care centres
“Information prescriptions” To integrate high-quality information into the healthcare pathway in a way
that is tailored to the needs of the individual
Information could be selected by the HCP and “prescribed” on the basis of
the individual patient’s needs, goals and the stage of their journey since
diagnosis
This may include information on PAH and its management including the
broader aspects of the disease beyond physical symptoms, as well as
referral to a local patient group
Written care plans Record of information about the patient’s care, which they can refer back to
between consultations
Helps the patient understand that there are a variety of options available to
them
Encourages the patient to consider their role in their own care
Emphasises the importance of collaboration and shared decision making
between the patient and HCP
Helps patients to communicate with local family doctors and HCPs in
shared care centres
Patient “passports” A digital or hard copy patient “passport” may be very useful for both patient
self-management and as a central record to improve information sharing
between the multidisciplinary team
May contain information on the disease, available treatments and written
care plan, a record of test results, information on self-care and the
broader aspects of the disease, and where to go for support
Helps patients to communicate with local family doctors and HCPs in
shared care centres
Patient self-assessment and management tools May be developed to assist patients in accessing information that is relevant
to them and their individual situations. Could be in the form of patient
“diaries”
Patient self-management courses Can be offered by the multidisciplinary team to educate and activate
patients early following the diagnosis of PAH
Patient-to-patient mentoring May provide patients with individualised support, particularly with regards
to the broader aspects of PAH beyond the physical symptoms
Patients could be matched according to factors such as age and cultural
background
Could take the form of chronic disease self-management programmes
where a patient with chronic disease is involved in leading the workshop,
providing advice and support to patients attending on how to best manage
their disease [41]
Promoting patient associations Training HCPs on the services available so that they can act as a conduit to
these services for patients
Training patient association members in marketing skills and activities via
social media and traditional routes to raise the profile and visibility of
patient associations among PAH patients
Data from [10].
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Role of patient associations
More than half of PAH patients and one-third of their carers feel socially isolated, due to a lack of
understanding of the disease among family, friends and the general public [5]. Patient associations are a
valuable asset in the management of PAH patients and provide support to HCPs in promoting patient
engagement. Patient associations provide opportunities for networking, meetings and social activities. They
also support patient advocacy and provide helplines, message boards and social media channels. They have
developed a wealth of information on PAH, exemplified by the Pulmonary Hypertension Library, which
contains over 200 resources with materials available in many languages for HCPs and patients to browse
[42]. In a quantitative survey of PAH patients, patient associations emerged as one of the most useful
sources of information for patients, with 66% of patients utilising them [5]. The majority of the patients
interviewed as part of this survey were members of a patient association [5].
Clinical PAH guidelines, including the latest ESC/ERS guidelines, recommend that patients be encouraged
to contact patient associations [3, 4]. Despite this, the aforementioned survey revealed that only 45% of
patients had been referred to these patient associations by a specialist [5, 43]. As PAH patients often seek
out patient associations at the time of diagnosis [43], patients and carers should be directed to these
organisations soon after this point [5].
Maintaining close links and effective communication between patient associations and the
multidisciplinary healthcare teams ensures that services, support and resources are optimally coordinated.
For patients who do not want to contact patient associations, their decision should be respected and
support given regarding whether any further sources of information are required.
Role of carers
Carers play a key role in supporting PAH patients with the management of their disease and with their
everyday physical and emotional needs [5, 43]. To encourage carers to be engaged, they too should be
provided with timely information and support [5, 43]. Most carers reportedly receive either limited or no
written information about PAH from HCPs at diagnosis, which leads to many unanswered questions [43].
However, as a group, carers are often more proactive than patients at obtaining information from a range
of sources [43]. By spending time with patients on a daily basis, carers are in a strong position to help and
encourage patients to engage in self-management of their disease. The need to include carers as important
stakeholders in the care provided to patients with PAH is thus recognised [43].
Role of expert patients
The concept of an “expert patient” is gaining increasing importance in healthcare policy and delivery [44].
Expert patient programmes are run by patient organisations to develop the confidence and skills of people
with chronic illnesses [45, 46]. They work together with HCPs and other health stakeholders to improve
patients’ QoL [45, 46]. As patients become experts in managing their chronic disease, their experience and
knowledge can be used to encourage others to become decision makers in their treatment process and to
further improve health services [47]. In PAH, expert patients can participate in working groups and
mentor newly diagnosed patients, further encouraging patient engagement. As self-management of chronic
diseases becomes increasingly recognised, the role of expert patients may continue to grow [47].
Future perspectives
There is growing public interest in digital health, not only to record and obtain information but also to
access electronic health records, conduct virtual HCP consultations and order repeat prescriptions [48].
Home-based, mobile and wearable technologies are becoming more widely available, which could impact
on patient engagement and self-management of their disease [49, 50]. Many patients already use
technology to monitor and manage their health. Apps and mobile devices that measure and track health
data have the potential to impact patient engagement and create increased awareness to reinforce beneficial
lifestyle choices [49]. The validity and reliability of measurements needs to be established and challenges
in adherence, privacy and clinical measurement need to be addressed before these devices are broadly
adopted [49]. For PAH, technology that measures energy consumption or adherence to treatment might
lead to advances in patient self-care, and input from patients on the development of mobile devices would
ensure they are user-friendly and enable patients to benefit in the best way possible.
Conclusion
Advancing knowledge and treatment options in PAH have improved the outlook for PAH patients,
making PAH a disease that patients can live with over the long term. Improved long term outcomes in
PAH patients mean that patient needs have evolved beyond those of treatment of symptoms and
managing disease progression. A holistic approach is now coming to the front of PAH management which
places the patient at the centre of their own healthcare. Patient engagement relies on the active
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collaboration between patients, HCPs and other stakeholders rather than the patient being a passive
recipient of their care. Multidisciplinary expert teams are essential and should include psychosocial
support for the patient. Patient associations are also a valuable resource for educational and emotional
support for patients and carers and play an essential role in patient care. In addition, expert patients are
emerging as sources of expertise and understanding to further encourage patient engagement. Tailored
support and education, shared decision making and support of self-care are some of the ways that patient
engagement can be achieved.
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